This page is part of the FHIR Specification (v1.8.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Provenance for Biocompute object examples
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- <http://hl7.org/fhir/Provenance/obj.1001> a fhir:Provenance; fhir:nodeRole fhir:treeRoot; fhir:Resource.id [ fhir:value "obj.1001"]; fhir:DomainResource.text [ fhir:Narrative.status [ fhir:value "generated" ]; fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: obj.1001</p><p><b>target</b>: <a>Procedure/example/_history/1.2</a></p><p><b>period</b>: 06/06/2017 --> (ongoing)</p><p><b>recorded</b>: 09/06/2016 8:12:14 AM</p><p><b>reason</b>: antiviral resistance detection (Details: [not stated] code null = 'null', stated as 'antiviral resistance detection')</p><p><b>policy</b>: <a>https://github.com/common-workflow-language/workflows/blob/master/workflows/lobSTR/lobSTR-workflow.cwl</a></p><blockquote><p><b>agent</b></p><p><b>role</b>: Author (Details: http://hl7.org/fhir/provenance-participant-role code author = 'Author', stated as 'null')</p><p><b>who</b>: <a>Practitioner/f204</a></p></blockquote><blockquote><p><b>agent</b></p><p><b>role</b>: Author (Details: http://hl7.org/fhir/provenance-participant-role code author = 'Author', stated as 'null')</p><p><b>who</b>: <a>Practitioner/f006</a></p></blockquote><blockquote><p><b>entity</b></p><p><b>role</b>: quotation</p><p><b>reference</b>: Identify baseline single nucleotide polymorphisms (SNPs[SO:0000694]), insertions[SO:0000667], and deletions[SO:0000045] that correlate with reduced ledipasvir[PubChem:67505836] antiviral drug efficacy in Hepatitis C virus subtype 1</p></blockquote><blockquote><p><b>entity</b></p><p><b>role</b>: quotation</p><p><b>reference</b>: Identify treatment emergent amino acid substitutions[SO:0000048] that correlate with antiviral drug treatment failure</p></blockquote><blockquote><p><b>entity</b></p><p><b>role</b>: quotation</p><p><b>reference</b>: Determine whether the treatment emergent amino acid substitutions[SO:0000048] identified correlate with treatment failure involving other drugs against the same virus</p></blockquote></div>" ]; fhir:Provenance.target [ fhir:index 0; fhir:link <http://hl7.org/fhir/Procedure/example/_history/1.2>; fhir:Reference.reference [ fhir:value "Procedure/example/_history/1.2" ] ]; fhir:Provenance.period [ fhir:Period.start [ fhir:value "2017-06-06"^^xsd:date ] ]; fhir:Provenance.recorded [ fhir:value "2016-06-09T08:12:14+10:00"^^xsd:dateTime]; fhir:Provenance.reason [ fhir:index 0; fhir:Coding.display [ fhir:value "antiviral resistance detection" ] ]; fhir:Provenance.policy [ fhir:value "https://github.com/common-workflow-language/workflows/blob/master/workflows/lobSTR/lobSTR-workflow.cwl"; fhir:index 0 ]; fhir:Provenance.agent [ fhir:index 0; fhir:Provenance.agent.role [ fhir:Coding.system [ fhir:value "http://hl7.org/fhir/provenance-participant-role" ]; fhir:Coding.code [ fhir:value "author" ] ]; fhir:Provenance.agent.whoReference [ fhir:link <http://hl7.org/fhir/Practitioner/f204>; fhir:Reference.reference [ fhir:value "Practitioner/f204" ] ] ], [ fhir:index 1; fhir:Provenance.agent.role [ fhir:Coding.system [ fhir:value "http://hl7.org/fhir/provenance-participant-role" ]; fhir:Coding.code [ fhir:value "author" ] ]; fhir:Provenance.agent.whoReference [ fhir:link <http://hl7.org/fhir/Practitioner/f006>; fhir:Reference.reference [ fhir:value "Practitioner/f006" ] ] ]; fhir:Provenance.entity [ fhir:index 0; fhir:Provenance.entity.role [ fhir:value "quotation" ]; fhir:Provenance.entity.reference [ fhir:Reference.display [ fhir:value "Identify baseline single nucleotide polymorphisms (SNPs[SO:0000694]), insertions[SO:0000667], and deletions[SO:0000045] that correlate with reduced ledipasvir[PubChem:67505836] antiviral drug efficacy in Hepatitis C virus subtype 1" ] ] ], [ fhir:index 1; fhir:Provenance.entity.role [ fhir:value "quotation" ]; fhir:Provenance.entity.reference [ fhir:Reference.display [ fhir:value "Identify treatment emergent amino acid substitutions[SO:0000048] that correlate with antiviral drug treatment failure" ] ] ], [ fhir:index 2; fhir:Provenance.entity.role [ fhir:value "quotation" ]; fhir:Provenance.entity.reference [ fhir:Reference.display [ fhir:value "Determine whether the treatment emergent amino acid substitutions[SO:0000048] identified correlate with treatment failure involving other drugs against the same virus" ] ] ] . <http://hl7.org/fhir/Procedure/example/_history/1.2> a fhir:Procedure . <http://hl7.org/fhir/Practitioner/f204> a fhir:Practitioner . <http://hl7.org/fhir/Practitioner/f006> a fhir:Practitioner . # -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.